Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06003985 · ClinicalTrials.gov registry record

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

A clinical trial of Point-of-care Ultrasound and Gastric Ultrasound, sponsored by Hospital for Special Surgery, New York.

Completed
Registry status
354
Enrollment target
8
Study locations

NCT06003985 is a study of Point-of-care Ultrasound and Gastric Ultrasound that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 354 participants. The trial reports 8 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06003985, a study of Point-of-care Ultrasound and Gastric Ultrasound, has completed, sponsored by Hospital for Special Surgery, New York.

COMPLETED
Registry status
354 participants
Enrollment target
8
Study locations

Study Summary

The aim of this study is to perform bedside gastric point of care ultrasound (POCUS) exams to assess the gastric volume and content (clear liquids vs solid food) perioperatively in patients who take glucagon-like peptide 1 (GLP-1) agonist medications compared to patients who do not take GLP-1 agonists.

Interventions

  • OTHER Gastric Ultrasound Exam

Study Locations (8)

New York

  • Albany Medical Center - Albany
  • Hospital for Special Surgery - New York
  • Memorial Sloan Kettering Cancer Center - New York
  • Weill Cornell Medicine - New York

District of Columbia

  • George Washington University Hospital - Washington D.C.

Florida

  • Mayo Clinic - Jacksonville

Virginia

  • University of Virginia - Charlottesville

Ontario

  • University Health Network - Toronto

Trial Details

FieldValue
Enrollment Target 354 participants
Start Date 2023-08-29
Est. Completion 2025-02-01

What the Registry Record Tells You About NCT06003985

The ClinicalTrials.gov registry entry for NCT06003985 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 354 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Point-of-care Ultrasound appearing as the primary indexed condition, and to 1 intervention - of which Gastric Ultrasound Exam is the first listed.

NCT06003985 reports 8 study locations spanning 5 distinct geographic areas - top geographies include New York, District of Columbia, Florida.

Frequently Asked Questions

What is clinical trial NCT06003985 about?

NCT06003985 is a clinical study titled "Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists". The aim of this study is to perform bedside gastric point of care ultrasound (POCUS) exams to assess the gastric volume and content (clear liquids vs solid food) perioperatively in patients who take glucagon-like peptide 1 (GLP-1) agonist medications compared to patients who do not take GLP-1 agonis...

What is the current status of trial NCT06003985?

This trial is currently completed. The enrollment target is 354 participants. The study started on 2023-08-29. Estimated completion is 2025-02-01.

What conditions does trial NCT06003985 study?

This clinical trial studies the following conditions: Point-of-care Ultrasound, Gastric Ultrasound, Glucagon-like Peptide 1.

What interventions are being tested in trial NCT06003985?

The interventions under investigation include: Gastric Ultrasound Exam (OTHER).

Who is sponsoring clinical trial NCT06003985?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06003985 being conducted?

This trial has 8 study locations across District of Columbia, Florida, New York, Virginia, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Point-of-care Ultrasound

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.